Sumatriptan and Naproxen Sodium
- Product NDC
- 0378-8755
- 11-digit product format
- 003788755
- Labeler code
- 0378
- Product ID
- 0378-8755_b9954dce-aec2-4429-9557-89ad3683ea4f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- sumatriptan and naproxen sodium
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- ANDA090872
- Marketing category
- ANDA
- Marketing start
- 2018-09-04
- Marketing end
- 2021-12-31
- Substance
- SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM
- Active strength
- 85 mg/1; mg/1
- Pharmacologic classes
- Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Serotonin 1b Receptor Agonists [MoA],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0378-8755-59 | 00378875559 | 9 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-8755-59) | 2018-09-04 | 0000-00-00 | No | No | Current |